Replies to post #154164 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

great comments as always. i do feel the P ph2b announcement was timely and think the given estimated trial timelines are very realistic. we have very good odds of a successful trial given the data to date. i feel very comfortable at $1.30 and it won't bother me a bit to see the price drop further if indeed that's the direction Mr. Market wants to go. Dilution is part of the process. Mark my words, there is a bottom and given the science and the progression of this company, I'm not alone when I say I'm holding tight. Our CEO has ran a very tight ship over the past few years in terms of dilution and rightly so. We're in a great position at the moment. When Mr. Market decides it's time to run, she will run and $1.30 is all but a guarantee so why sell now. This is one of the benefits of our current share price especially in terms of accumulation. I believe in this company. I believe in the science. I believe in management. Go CTIX

[Amatuer17]

BD - thanks - right to go with p2b.
When you say it will be quick -it will be min 6-8 months - correct?

It has 12 weeks of follow up - so min 3 months from last patient enrollment plus 1 month unblinding.

So if we start in Q4-2016, it will go till Q3-2017

[stevo99]

I agree bio, either one off the licensing deals for each indication or do an all encompassing B platform deal with upfront cash, milestone payments, and share of profits. Haven't other biotechs done this? Isn't that how Pharmacyclics ended up being sold for $21 Billion for the half of their platform they still owned?